Adjuvant Pembrolizumab for Surgically Treated Clear Cell Renal Cell Carcinoma: Results from a UK Tertiary Renal Cancer Network.
- DOI
- 10.1016/j.euo.2026.09.002
- Published
- 2026 Sep 24
- Container
- European urology oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.euo.2026.09.002,
title = {Adjuvant Pembrolizumab for Surgically Treated Clear Cell Renal Cell Carcinoma: Results from a UK Tertiary Renal Cancer Network.},
author = {Sordelli F and Basile G and Roussel E and Kudva V and Hughes D and Nally E and Barod R and Reekhaye A and Yao M and Hani A and Patki P and Mumtaz F and Sheikh SE and Sedigh O and Buffi NM and Boleti E and Powles T and Bex A and Rullan A},
year = {2026},
journal = {European urology oncology},
doi = {10.1016/j.euo.2026.09.002},
url = {https://doi.org/10.1016/j.euo.2026.09.002}
}RIS
TY - JOUR TI - Adjuvant Pembrolizumab for Surgically Treated Clear Cell Renal Cell Carcinoma: Results from a UK Tertiary Renal Cancer Network. AU - Sordelli F AU - Basile G AU - Roussel E AU - Kudva V AU - Hughes D AU - Nally E AU - Barod R AU - Reekhaye A AU - Yao M AU - Hani A AU - Patki P AU - Mumtaz F AU - Sheikh SE AU - Sedigh O AU - Buffi NM AU - Boleti E AU - Powles T AU - Bex A AU - Rullan A PY - 2026 JO - European urology oncology DO - 10.1016/j.euo.2026.09.002 UR - https://doi.org/10.1016/j.euo.2026.09.002 ER -
APA
F, S., G, B., E, R., V, K., D, H., E, N., R, B., A, R., M, Y., A, H., P, P., F, M., SE, S., O, S., NM, B., E, B., T, P., A, B., & A, R. (2026). Adjuvant Pembrolizumab for Surgically Treated Clear Cell Renal Cell Carcinoma: Results from a UK Tertiary Renal Cancer Network.. European urology oncology. https://doi.org/10.1016/j.euo.2026.09.002
Source records
- pubmed · retrieved 2026-09-25T08:17:00.698Z